Preliminary clinical and biologic results of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab, in advanced solid tumors (KEYNOTE A36).

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 9|浏览24

暂无评分

关键词

oral cd11b modulator,pembrolizumab,advanced solid tumors,biologic results,gb1275,first-in-class

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要